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CBA/N  mice,  a  mutant  subline  of the  CBA/Ca  strain,  have  a  marked 
abnormality in bone marrow-derived, B-lymphocyte  function, which is inherited 
as an X-linked recessive trait (1, 2). CBA/N mice and immunologically abnor- 
mal FI male mice derived from this strain fail to produce specific antibody after 
immunization with certain '~thymus-independent" antigens (1-4). Moreover, in 
vitro analysis of spleen cells derived from these mice demonstrates diminished 
proliferative responses to B-cell  mitogens (5,  6); reduced killing in antibody- 
dependent, cell-mediated cytotoxicity assays (5); and an inability to form B- 
lymphocyte colonies in agar cultures after stimulation with bacterial lipopoly- 
saccharide (LPS)  (7). Analysis of the surface membrane characteristics of B 
lymphocytes derived from immune defective CBA/N  and from normal mice 
indicated that the functional abnormality of CBA/N mice was associated with a 
deficiency in a subpopulation of splenic B lymphocytes (8-11). This subpopula- 
tion is first d~tected in the spleens of normal mice at 2-3 wk after birth and has 
been characterized as  (a) bearing both surface IgM and the putative mouse 
homologue of human IgD (12); (b) functionally expressing minor lymphocyte- 
activating determinants (13-15); and (c) bearing Lyb5 antigens (16). 
The apparent deficiency of a B-lymphocyte subset in the CBA/N mice in the 
absence  of  any  evidence  of T-lymphocyte functional  abnormalities  (5,  17) 
provides  an  interesting  model  to  study  the  mechanisms  involved  in  the 
acceptance or rejection of engrafted lymphoid tissue in a nonirradiated recipi- 
ent. Earlier functional studies suggested that stable chimerism occurred when 
lymphoid cells of immunologically normal (CBA/N  ×  DBA/2)F1 female mice 
were given to nonirradiated, immunologically deficient (CBA/N  ×  DBA/2)F1 
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male mice (3). Thus, F~ male mice who received F~ female cells were shown to 
be responsive to antigens to which they were normally unresponsive; and in 
vitro  experiments  suggested  that  such  reconstitution  was  not  due  to  the 
development of responsiveness in F~ male cells secondary to the influence of F1 
female cells (18). 
To study this phenomenon further, immunologically abnormal CBA/N and 
normal CBA/CaHN mice, who are known to reciprocally accept skin grafts, (A. 
K.  Berning and I.  Scher, unpublished observations) were given spleen cells 
from  CBA/CaHN-T6  mice  without  preparative  radiation  or  other  immuno- 
suppression; and the distribution of the transplanted cells and their responsive- 
ness to phytohemagglutinin (PHA) or LPS was determined. 
Materials and Methods 
Mice.  CBA/CaHN,  chromosomally-marked  CBA/CaHN-T6,  and  immune  defective  CBA/N 
mice  were  obtained  from  the  Division  of Research  Services,  National  Institutes  of Health, 
Bethesda,  Md. 
Analysis for the Presence ofT6 Cells.  At various time intervals after receiving 50 × l0  s viable 
nucleated  CBA/CaHN-T6 spleen  cells,  groups  of recipient mice were  injected  with  colchicine 
(CLC) intraperitoneally (100 ~tg of CLC dissolved in 0.5 ml of distilled water). 3 h later, the mice 
were killed by cervical dislocation and bone marrow, thymus lymph node, Peyer's patches,  and 
spleen cells were harvested and processed for chromosome studies by the modified squash method 
described elsewhere  (19). Briefly, 5  ×  l0  s cells were suspended  in 2  ml of RPML1640  (Grand 
Island Biological Co., Grand Island, N.Y.) medium and 2 ml of distilled water. After 5 min, the 
cells were recovered by centrifugation  and  fixed by adding 2 ml of glacial acetic acid:distilled 
water (1 vohl vol) for 10 min. After a second centrifugation, the fLxed cells were transferred to a 
clean slide and squashed for chromosome studies. The slides were stained with Wright's stain and 
analyzed with light microscopy. Utilizing this method of preparation, one can distinguish between 
the donor CBA/CaHN-T6 mitotic cells, bearing two easily recognizable tiny chromosomes (T6T6), 
and  the  host  mitotic cells,  which  lack these chromosome "markers"  in  their karyotype.  In  a 
second series of experiments, single-cell suspensions of 5 ×  10  ~ cells were prepared in RPMI-1640 
(supplemented with 100 U/ml of penicillin, 100/~g/ml of streptomycin, 2 mM 1-glutamine, 25 mM 
Hepes, and 5% heat-inactivated, pooled human serum). These suspensions were cultured in dupli- 
cate with either the T-cell mitogen PHA (2 ~g/culture; Wellcome Research Laboratories, Becken- 
ham,  England),  the B-cell mitogen LPS  (100  ~g/culture; 011hB4,  Difco Laboratories,  Detroit, 
Mich.), or media as a control as previously described (20). 
Results 
When immunologically  normal (CBA/CaHN) or abnormal (CBA/N) recipients 
were given 50  ×  106  CBA/CaHN-T6 spleen cells, no donor T6T6 mitotic cells 
were detected in the bone marrow or the thymus 2-5 wk after transplantation 
(Table I). Small numbers ofT6 mitoses were detected in the spleen, lymph node, 
and Peyer's patches of 4 of 8 CBA/CaHN recipients, although their frequency 
was no greater than 1 of 47 (T6T6 mitoses/total mitoses). In contrast, donor T6 
mitotic cells were detected in the Peyer's patches, spleen, and lymph nodes of 8 
of 8 CBA/N recipients, with an incidence which ranged from 2 of 85  (2%) in 
Peyer's patches at 2 wk to 9 of 17 (53%) in lymph nodes at 3 and 4 wk. The level 
of chimerism within the different organs of engrafted CBA/N mice appeared to 
be stable during the time interval studied, except in the case of Peyer's patches, 
where the frequency increased from 2% at 2 wk to ->18% thereafter. 
To  study the  functional characteristics of engrafted CBA/CaHN-T6  cells, 
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TABLE  I 
Frequency of CBA/CaHN-T6 Mitotic Cells in the Lymphohematopoietic  Organs of 
Normal Adult (CBA/Ca) or B-Lymphocyte-Deficient  (CBA/N) Mice Given 50  × 
106 CBAICaHN-T6 Spleen Cells Intravenously* 
Recipient strain  Organ 
No. of  T6T6 mitoses/total  mitoses scored (Time in weeks after  the 
injection  of  T6T6 spleen cells) 
2  3  4  5 
CBA/Ca 
CBA/N 
Bone marrow  0/115  0/97  0/120  0/103 
Thymus  0/25  0/9  0/35  0/19 
Spleen  1/66  0153  0/77  0/45 
Lymph node  0/12  1/52  0/16  1/47 
Peyer's  patches  0/53  1/72  0/50  0/8 
Bone marrow  0/115  0/119  0/278  0/326 
Thymus  0/19  0/29  0/26  0/11 
Spleen  24/108  5/43  5/47  3/20 
Lymph node  6/36  9/17  9/17  9/24 
Peyer's patches  2/85  25/93  6/34  5/18 
* These data represent the number of  T6T6 mitoses of  total  mitoses scored for  two animals at  each time interval. 
2-5 wk previously were cultured in vitro with the T- or B-cell mitogens, PHA, 
or  LPS.  Under  these  conditions,  the  frequency of CBA/CaHN-T6  mitoses  in 
engrafted  CBA/CaHN mice was similar to those observed in the experiments 
described above; and no differences were observed between the PHA- or LPS- 
stimulated cultures (PHA stimulation -<6 of 280 or 2.1%; LPS stimulation -<4 of 
140 or 2.8%; eight individual mice examined with at least 140 mitoses counted). 
By contrast,  the results obtained after stimulation of engrafted CBA]N spleen 
cells with PHA or LPS were distinct from each other and  different from the 
experiments  detailing  organ  distribution.  The  incidence  of  CBA/CaHN-T6 
mitoses in PHA-stimulated cultures was -<38 of 478 or 7.9%, a lower figure than 
that observed in both the unstimulated in vitro cultures (Table II), and in the 
organ  distribution  analysis  (Table I).  However, stimulation  of the  engrafted 
CBA/N  spleen  cells with  LPS induced frequencies of CBA/CaHN-T6 mitoses 
that were higher  194 of 377 or 51.4%;  312 of 445,  or 70.1%)  than observed with 
unstimulated spleen cells derived from CBA/N mice in all experiments (Tables 
I and II). 
Discussion 
These  data  support  previous  studies  (21)  which  demonstrate  little,  if any, 
engraftment of donor cells after their administration  to syngeneic, unprepared 
normal  recipients.  The  mechanisms  responsible for the nonacceptance  of the 
donor cells under these circumstances are unknown, but it has been postulated 
that  in  order for successful engraftment  to occur,  recipients  of bone marrow 
must provide a  suitable microenvironment  (22).  This microenvironment  must 
allow for the physical expansion of the donor cells (space) and provide for the 
necessary  humoral  and/or  cellular  factor(s)  necessary  for  cell  engraftment. 
Further  insight  into  this  problem  has  been  provided  by  two  experimental 
systems. The first such system described involved mice that are homozygous for 
mutant genes at the W locus, resulting in a  stem-cell abnormality which leads 
to  severe macrocytic anemia  (23).  Recent  data  reported  from  our laboratory 
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TABLE II 
Frequency of CBA/CaHN-T6 Mitotic Cells in Mitogen-lnduced  Spleen Cultures 
From B-Lymphocyte-Deficient  (CBA/N) Mice Given 50  × 106 CBA/CaHN-T6T6 
Spleen Cells Intravenously 
Months after injection  Number of ani- 
of T6T6 spleen cells  reals 
No. of T6T6 Mitoses/total  mitoses scored (%) 
Media  control  PHA  LPS 
1  1  3/14  (21.4%)  6/256  (2.3%)  9/19  (64.2%) 
2  3  4/27  (14.8%)  13/370 (3.5%)  194/377 (51.4%) 
3  2  7/22 (31.8%)  18/350 (5.1%)  202/345 (58.5%) 
4  3  7/23 (30.4%)  38/478  (7.9%)  312/445  (70.1%) 
* The spleens of the CBA/N hoot mice were removed, single cell suspensions prepared, and cells cultured in the presence 
of PHA,  LPS, or media as a  control.  After 3 days in culture,  the dividing cells were arrested in metaphase by the 
addition of CLC and chromosome analysis was performed. 
subpopulation  (24). When such mice are given bone marrow or spleen grafts 
from histocompatible, normal T6 donors, a stable chimera develops with a large 
frequency of donor cells apparent in all hematopoietic and lymphoid organs (25). 
In the second system, after CBA/H mice were made T-lymphocyte-deficient  by 
neonatal thymectomy, they accepted engraftment of normal T6T6 spleen cells, 
although  the  engrafted  donor  cells  were  only  found  in  lymph  nodes  (20). 
Presumably, in both of these systems, the absence of a population of cells in the 
recipient animals  (as a  result of a  stem-cell defect or by depletion of T  cells) 
allowed for engraftment because of the availability of space in the setting of an 
appropriate humoral and cellular milieu. 
CBA/N  mice  demonstrate  engrafted  CBA/CaHN-T6  cells  in  their  Peyer's 
patches,  spleens,  and lymph nodes, but not bone marrow or thymus glands. 
This organ distribution is exactly that of a  subpopulation of late-developing B 
lymphocytes, which can be identified in normal mice, but which are deficient in 
CBA/N mice (8-16). These findings suggest that there is a selective engraftment 
of T6  cells  in  CBA/N  mice and  that  the  cells  which are  successful in  this 
engraftment may represent a distinct B-lymphocyte subpopulation. This view is 
supported by the increase in frequency of T6 cells obtained from the spleens of 
engrafted CBA/N mice after stimulation in vitro with LPS in the absence of a 
PHA-induced T6 proliferative response. The selectivity of engrafted lymphoid 
cells seen in these experiments is similar to that observed in the T-cell-depleted 
CBA/H  system, where engrafted cells can only be found in  recipient lymph 
nodes (21). By contrast, normal donor cells are found in all lymphoid organs but 
in varying amounts of engrafted W/W  v mice who have a defective multipotential 
stem cell  (25). Studies of these three experimental systems demonstrate that 
engraftment of donor lymphoid tissues in unprepared hosts can occur if the host 
has  a  deficiency in  a  lymphoid-cell population.  Moreover, the current study 
suggests that engraftment occurs in a specific manner and provides a model in 
which to study the mechanisms by which a  host rejects or accepts syngeneic 
donor cells. 
Summary 
Nonirradiated B-lymphocyte-deficient CBA/N mice given T6T6 chromosome- 
marked normal CBA/CaHN spleen ceils became lymphoid chimeras exhibiting 
donor-type mitoses.  Normal CBA/CaHN recipients did not exhibit significant 944  D.  VOLF  ET AL.  BRIEF  DEFINITIVE  REPORT 
numbers of donor-type mitoses. The lymphoid cell chimerism in the CBA/N host 
appeared in spleen, lymph nodes, and Peyer's patches, but not in bone marrow 
or thymus. Stimulation of CBA/N-recipient spleen cells in vitro suggested that 
the  chimerism involved donor T6T6  cells  which were  responsive to  the  B- 
lymphocyte mitogen, lipopolysaccharide, but not to the T-lymphocyte mitogen, 
phytohemagglutinin. These data indicate that stable, long-term chimerism of a 
specific class of lymphocytes is possible in nonirradiated, B-lymphocyte-defi- 
cient CBMN mice. 
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